Skip to main content
| News

DayOne Tech supports three medtech startups

18.08.2022

DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of Jura with three startups. CNS Therapy, Moonlight AI, and CryoThermo 4.0 will receive access to coaching, the ecosystem, office space, and funds over twelve months.

Three medtech startups began their year-long journey through DayOne Tech’s acceleration program in the canton of Jura on August 17. According to a press release, they are CNS TherapyMoonlight AI, and CryoThermo 4.0. They will gain access to coaching, the ecosystem, office space, and funds. The healthcare innovation initiative from Basel Area Business & Innovation, an investment and innovation promotion agency, brings together professionals and specialists from various disciplines and companies in the Basel Area to strengthen the healthcare ecosystem and make it more sustainable.

Three startups selected

CNS Therapy from Zug has developed a treatment for chronic pain without medication, surgery, or implants. Its systolic extinction therapy, for example, using neuromodulation and behavioral therapy has been proven effective in randomized studies. It is an innovative, interactive behavioral therapy combined with a patented medical device.

Moonlight AI with headquarters at the Switzerland Innovation Park Basel Area – Jura in Courroux in the Swiss canton of Jura develops artificial intelligence models to predict genomic biomarkers that are therapeutically relevant. It uses scans of stained hematology or pathology slides to do so. The startup aims to use these to democratize access to genomic information for therapeutic decisions.

CryoThermo 4.0 is developing a new generation of patented medical thermal compresses “thanks to a technological and therapeutic paradigm shift”. The startup also plans to manufacture and market these. The aim is to become the global leader in this area.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

KUORI developing biodegradable plastics
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Cell and gene therapies gain momentum in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
AMR Action Fund invests in new antibiotics developed by BioVersys
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Investors give Resistell 8.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.